NCT06383338 2025-09-08
PEGASUS
Murdoch Childrens Research Institute
Phase 1 Recruiting
Clinical Trials
5 trialsNCT00001337 2025-06-22
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03028103 2023-06-26
Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients
Ipsen
Phase 1 Completed
NCT00201422 2016-03-28
Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma
National Health Research Institutes, Taiwan
Phase NA Completed
NCT00003151 2012-07-02
Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed